Latest Breaking News On - Kazuko matsuda - Page 5 : comparemela.com

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Kazuko-matsuda
Geoff-obrienvice-presidentmedicinova-inc
Department-of-health
Human-services
Medicinova-inc
Us-department-of-health
Development-authority
Administration-for-strategic-preparedness
Exchange-commission
Biomedical-advanced-research

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury

MediciNova Announces Results of Studies under BARDA Contract to Develop MN 166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Geoff-obrien
Kazuko-matsuda
Exchange-commission
Biomedical-advanced-research
Nasdaq
Us-department-of-health
Development-authority
Administration-for-strategic-preparedness
Medicinova-inc
Department-of-health

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe

MediciNova Receives a Notice of Intention to Grant for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Geoff-obrien
Kazuko-matsuda
Medicinova-inc
European-patent-office
Nasdaq
Exchange-commission
Trademark-office
Nova-receives
New-patent-covering
Macular-injury

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Scleroderma and Systemic Sclerosis in Europe
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Canada
Tokyo
Japan
Canadian
Geoff-obrien
Kazuko-matsuda
Juntendo-university
Canadian-intellectual-property-office
Exchange-commission
Medicinova-inc
Nasdaq
European-patent-office

Medicinova (MNOV) Granted New Patent Covering MN-001

Medicinova (MNOV) Granted New Patent Covering MN-001
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Tokyo
Japan
Canada
Canadian
Kazuko-matsuda
Geoff-obrien
Medicinova-inc
Juntendo-university
Canadian-intellectual-property-office
Exchange-commission
European-patent-office
Nasdaq